Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Period 1 (Double Blind): 1-12 Weeks	STARTED	Etanercept BIW/QW	379
Period 1 (Double Blind): 1-12 Weeks	STARTED	Etanercept QW/QW	373
Period 1 (Double Blind): 1-12 Weeks	COMPLETED	Etanercept BIW/QW	364
Period 1 (Double Blind): 1-12 Weeks	COMPLETED	Etanercept QW/QW	362
Period 1 (Double Blind): 1-12 Weeks	NOT COMPLETED	Etanercept BIW/QW	15
Period 1 (Double Blind): 1-12 Weeks	NOT COMPLETED	Etanercept QW/QW	11
Period 2 (Open Label): 13-24 Weeks	STARTED	Etanercept BIW/QW	364
Period 2 (Open Label): 13-24 Weeks	STARTED	Etanercept QW/QW	362
Period 2 (Open Label): 13-24 Weeks	COMPLETED	Etanercept BIW/QW	350
Period 2 (Open Label): 13-24 Weeks	COMPLETED	Etanercept QW/QW	344
Period 2 (Open Label): 13-24 Weeks	NOT COMPLETED	Etanercept BIW/QW	14
Period 2 (Open Label): 13-24 Weeks	NOT COMPLETED	Etanercept QW/QW	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00245960/flow